House committee to discuss safety of US supply chain after 2 major drug recalls

A House subcommittee will hold a hearing Oct. 30 to discuss the safety of the U.S. drug supply chain after two major drugs were recalled due to potential carcinogens, according to Politico’s Prescription Pulse newsletter.

Advertisement

Three generic blood pressure drugs — valsartan, losartan and irbesartan — as well as the heartburn drug Zantac were all recently recalled after potentially carcinogenic impurities were found in their active ingredients.

The active ingredient for the three blood pressure drugs was manufactured in China and its makerknew of the impurities, but failed to report the information, according to Politico.

The House Energy and Commerce Health Subcommittee will focus the meeting on the role of international drug companies in the U.S. drug supply chain.

More articles on pharmacy:
Novant Health leaders talk Walgreens partnership goals for 2020
Sanofi recalls heartburn drug over cancer risks
Centura Health opens retail pharmacy

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.